Literature DB >> 22961006

The effect of enteral supplementation of specific neutral and acidic oligosaccharides on the faecal microbiota and intestinal microenvironment in preterm infants.

E A M Westerbeek1, R A Slump, H N Lafeber, J Knol, G Georgi, W P F Fetter, R M van Elburg.   

Abstract

We aimed to determine the effects of enteral supplementation of a prebiotic mixture of neutral and acidic oligosaccharides (scGOS/lcFOS/pAOS) on the faecal microbiota and microenvironment in preterm infants. Furthermore, we determined the influence of perinatal factors on the development of the faecal microbiota. In a randomised controlled trial, preterm infants with gestational age <32 weeks and/or birth weight <1,500 g received enteral supplementation of scGOS/lcFOS/pAOS or placebo (maltodextrin) between days 3 and 30 of life. Faecal microbiota, as measured with fluorescent in situ hybridisation (FISH), and microenvironment [short-chain fatty acids (SCFAs), pH, sIgA] were measured at four time points: before the start of the study and at days 7, 14 and 30 of life. In total, 113 preterm infants were included. Enteral supplementation of the prebiotic mixture increased the total bacteria count at day 14 (Exp 3.92; 95 % confidence interval [CI] 1.18-13.04, p = 0.03), but not at day 30 (Exp 1.73; 95 % CI 0.60-5.03, p = 0.31). There was a trend toward increased bifidobacteria counts. There was a delayed intestinal colonisation of all bacteria. Enteral supplementation of the prebiotic mixture decreased the faecal pH (Exp 0.71; 95 % CI 0.54-0.93, p = 0.01) and there was a trend toward increased acetic acid compared to the placebo group (Exp 1.09; 95 % CI 0.99-1.20, p = 0.10). There was no effect on sIgA (Exp 1.94; 95 % CI 0.28-13.27, p = 0.50). Antibiotics decreased the total bacteria count (Exp 0.13; 95 % CI 0.08-0.22, p < 0.001). Enteral supplementation of a prebiotic mixture of neutral and acidic oligosaccharides increases the postnatal intestinal colonisation. However, the extensive use of broad-spectrum antibiotics in preterm infants decreased the growth of all intestinal microbiota, thereby, delaying the normal microbiota development.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22961006     DOI: 10.1007/s10096-012-1739-y

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  30 in total

1.  Influence of mode of delivery on gut microbiota composition in seven year old children.

Authors:  S Salminen; G R Gibson; A L McCartney; E Isolauri
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

2.  IS-pro: high-throughput molecular fingerprinting of the intestinal microbiota.

Authors:  A E Budding; M E Grasman; F Lin; J A Bogaards; D J Soeltan-Kaersenhout; C M J E Vandenbroucke-Grauls; A A van Bodegraven; P H M Savelkoul
Journal:  FASEB J       Date:  2010-07-19       Impact factor: 5.191

Review 3.  The intestinal bacterial colonisation in preterm infants: a review of the literature.

Authors:  Elisabeth A M Westerbeek; Anemone van den Berg; Harrie N Lafeber; Jan Knol; Willem P F Fetter; Ruurd M van Elburg
Journal:  Clin Nutr       Date:  2006-05-04       Impact factor: 7.324

4.  Influence of antibiotic exposure in the early postnatal period on the development of intestinal microbiota.

Authors:  Shigemitsu Tanaka; Takako Kobayashi; Prapa Songjinda; Atsushi Tateyama; Mina Tsubouchi; Chikako Kiyohara; Taro Shirakawa; Kenji Sonomoto; Jiro Nakayama
Journal:  FEMS Immunol Med Microbiol       Date:  2009-04-06

Review 5.  Pathologic and physiologic interactions of bacteria with the gastrointestinal epithelium.

Authors:  L Lu; W A Walker
Journal:  Am J Clin Nutr       Date:  2001-06       Impact factor: 7.045

6.  Faecal SIgA secretion in infants fed on pre- or probiotic infant formula.

Authors:  A M Bakker-Zierikzee; E A F Tol; H Kroes; M S Alles; F J Kok; J G Bindels
Journal:  Pediatr Allergy Immunol       Date:  2006-03       Impact factor: 6.377

7.  Short-chain fatty acids and polyamines in the pathogenesis of necrotizing enterocolitis: Kinetics aspects in gnotobiotic quails.

Authors:  A J Waligora-Dupriet; A Dugay; N Auzeil; I Nicolis; S Rabot; M R Huerre; M J Butel
Journal:  Anaerobe       Date:  2009-02-20       Impact factor: 3.331

8.  Mucosal IgA, mucosal cow's milk antibodies, serum cow's milk antibodies and gastrointestinal permeability in infants.

Authors:  M Kuitunen; E Savilahti
Journal:  Pediatr Allergy Immunol       Date:  1995-02       Impact factor: 6.377

9.  Faecal short chain fatty acids in breast-fed and formula-fed babies.

Authors:  C A Edwards; A M Parrett; S E Balmer; B A Wharton
Journal:  Acta Paediatr       Date:  1994-05       Impact factor: 2.299

10.  Potential roles and clinical utility of prebiotics in newborns, infants, and children: proceedings from a global prebiotic summit meeting, New York City, June 27-28, 2008.

Authors:  Philip M Sherman; Michael Cabana; Glenn R Gibson; Berthold V Koletzko; Josef Neu; Gigi Veereman-Wauters; Ekhard E Ziegler; W Allan Walker
Journal:  J Pediatr       Date:  2009-11       Impact factor: 4.406

View more
  16 in total

Review 1.  Prevention of Necrotizing Enterocolitis Through Manipulation of the Intestinal Microbiota of the Premature Infant.

Authors:  Kannikar Vongbhavit; Mark A Underwood
Journal:  Clin Ther       Date:  2016-02-09       Impact factor: 3.393

2.  Metaproteomics reveals functional differences in intestinal microbiota development of preterm infants.

Authors:  Romy D Zwittink; Diny van Zoeren-Grobben; Rocio Martin; Richard A van Lingen; Liesbeth J Groot Jebbink; Sjef Boeren; Ingrid B Renes; Ruurd M van Elburg; Clara Belzer; Jan Knol
Journal:  Mol Cell Proteomics       Date:  2017-07-06       Impact factor: 5.911

Review 3.  The role of early life nutrition in the establishment of gastrointestinal microbial composition and function.

Authors:  Erin C Davis; Mei Wang; Sharon M Donovan
Journal:  Gut Microbes       Date:  2017-01-09

4.  Systematic Review of the Effect of Enteral Feeding on Gut Microbiota in Preterm Infants.

Authors:  Wanli Xu; Michelle P Judge; Kendra Maas; Naveed Hussain; Jacqueline M McGrath; Wendy A Henderson; Xiaomei Cong
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2017-10-14

Review 5.  Validity of food additive maltodextrin as placebo and effects on human gut physiology: systematic review of placebo-controlled clinical trials.

Authors:  Rawan Almutairi; Abigail Raffner Basson; Fabio Cominelli; Pamela Wearsh; Alexander Rodriguez-Palacios
Journal:  Eur J Nutr       Date:  2022-03-01       Impact factor: 4.865

Review 6.  Prenatal and postnatal administration of prebiotics and probiotics.

Authors:  Kristin Sohn; Mark A Underwood
Journal:  Semin Fetal Neonatal Med       Date:  2017-07-15       Impact factor: 3.926

7.  Effect of a combination GOS/FOS® prebiotic mixture and interaction with calcium intake on mineral absorption and bone parameters in growing rats.

Authors:  Gabriel Bryk; Magalí Zeni Coronel; Gretel Pellegrini; Patricia Mandalunis; María Ester Rio; María Luz Pita Martín de Portela; Susana Noemí Zeni
Journal:  Eur J Nutr       Date:  2014-09-21       Impact factor: 5.614

Review 8.  Bifidobacterium longum subspecies infantis: champion colonizer of the infant gut.

Authors:  Mark A Underwood; J Bruce German; Carlito B Lebrilla; David A Mills
Journal:  Pediatr Res       Date:  2014-10-10       Impact factor: 3.756

9.  Bifidobacterium breve BBG-001 and intestinal barrier function in preterm babies: Exploratory Studies from the PiPS Trial.

Authors:  Paul Fleming; Mark Wilks; Simon Eaton; Nicola Panton; Richard Hutchinson; Abena Akyempon; Pollyanna Hardy; Michael R Millar; Kate Costeloe
Journal:  Pediatr Res       Date:  2020-09-18       Impact factor: 3.756

10.  Neutral and acidic oligosaccharides supplementation does not increase the vaccine antibody response in preterm infants in a randomized clinical trial.

Authors:  Jolice P van den Berg; Elisabeth A M Westerbeek; Fiona R M van der Klis; Guy A M Berbers; Harrie N Lafeber; Ruurd M van Elburg
Journal:  PLoS One       Date:  2013-08-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.